BMS plans to remodel its downsized Syracuse plant

Bristol-Myers Squibb plans to demolish half of the 118 buildings at its East Syracuse operation in a facelift that reflects the changes that have occurred inside the drug plant. Report

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.